{"disease":{"id":"mmrd-msi-h-stage-ii-iii-endometrial-cancer","name":"mmrd msi h stage ii iii endometrial cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07013851","title":"Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Grupo Español de Investigación en Cáncer de Ovario","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}